Inclusion Criteria:

- Histologically documented squamous cell carcinoma or adenocarcinoma of the thoracic
esophagus (> 20cm from the incisors) or gastroesophageal junction are included.

- No distant metastases (M0).

- Patients will be stratified by stage (clinical N0 versus clinical N1).

- Patients with tumours within 3 cm distal spread into gastric cardia as detected by
esophagogastroscopy.

- Resectable mediastinal nodes are eligible.

- No prior chemotherapy for this malignancy.

- No prior radiotherapy that would overlap the field(s) treated in this study.

- Patients with other malignancies are eligible only if > 5 years without evidence of
disease or completely resected or treated non-melanoma skin cancer.

- Age > 18 years and able to tolerate tri-modality therapy at the discretion of the
treating thoracic surgeon, medical and radiation oncologists. Tumours must be
resectable after assessment by the thoracic surgeon.

Exclusion Criteria:

- Cancers of the cervical esophagus (< 20 cm are excluded).

- Tumours that have > 3 cm of spread into cardia of the stomach are considered gastric
cancers and are ineligible.

- Patients with biopsy (by endoscopic ultrasound, laparoscopy, or laparotomy ) proven
metastatic supraclavicular nodes are ineligible.

- Patients with biopsy proven metastatic celiac nodes are ineligible.